7037 Clinical, biochemical (PSA) and radiographic benefit with sunitinib as a single agent in metastatic chemoresistant and hormone-refractory prostate cancer (HRPC) patients

✍ Scribed by Castellano, D.; Larriba, J. Gonzalez; Aparicio, L.M. Antón; Casinello, J.; Grande, E.; Esteban, E.; Sepulveda, J.; Rodriguez, A.; Cañete, I. Ghanem

• Book ID: 121967787
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 50 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/S1359-6349(09)71415-6